Harry Burn
Sound Shore Management
Harry Burn Elevance Health Inc stake
total: 197
Sound Shore Management ELV trades
- Total transactions:
- 20
- New positions:
- 4
- Sold out:
- 3
- Added:
- 4
- Reduced:
- 9
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Harry Burn holds 243,452 Elevance Health Inc (ELV) shares with a market value of roughly $94.15M accounting for 2.90% of the overall portfolio. To date, the estimated cost basis is nearly $386.73 for "buy" trades. Sound Shore Management first purchased ELV in 2014 Q4, initially acquiring about 1.35M shares. Harry Burn later completely sold out the position and invested in Elevance Health Inc again in 2026 Q2. Since the initial investment in Elevance Health Inc (ELV), Sound Shore Management has made 19 more transactions.
When did Harry Burn buy Elevance Health Inc (ELV)?
Harry Burn first invested in Elevance Health Inc (ELV) in 2014 Q4 at the reported quarter-end price of $125.67 per share.
What's the cost basis of Sound Shore Management's ELV stake?
The estimated cost basis for Elevance Health Inc (ELV) stake is around $386.73 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $386.73
Harry Burn's historical trades in Elevance Health Inc
20 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.90%
|
243,452
|
$386.73
|
$94,150,192
|
new
|
+2.9%
|
|
2024 Q4
|
0.00%
|
0
|
$520.00
|
|
-100% (-119,497)
|
-2.02%
|
|
2024 Q3
|
2.02%
|
119,497
|
$520.00
|
$62,138,440
|
-2.11% (-2,572)
|
-0.04%
|
|
2024 Q2
|
2.21%
|
122,069
|
$541.86
|
$66,144,309
|
-21.06% (-32,574)
|
-0.55%
|
|
2024 Q1
|
2.51%
|
154,643
|
$518.54
|
$80,188,581
|
+3.14% (+4,713)
|
+0.08%
|
|
2023 Q4
|
2.45%
|
149,930
|
$471.56
|
$70,700,991
|
-0.16% (-247)
|
-0%
|
|
2023 Q3
|
2.50%
|
150,177
|
$435.42
|
$65,390,069
|
+27.93% (+32,790)
|
+0.55%
|
|
2023 Q2
|
1.92%
|
117,387
|
$444.29
|
$52,153,871
|
new
|
+1.92%
|
|
2022 Q3
|
0.00%
|
0
|
$482.58
|
|
-100% (-125,137)
|
-2.21%
|
|
2022 Q2
|
2.21%
|
125,137
|
$482.58
|
$60,389,000
|
-21.32% (-33,912)
|
-0.48%
|
|
2022 Q1
|
2.27%
|
$491.22
|
-27.19% (-59,404)
|
|||
|
2021 Q4
|
2.81%
|
$463.54
|
-9.85% (-23,876)
|
|||
|
2021 Q3
|
2.55%
|
$372.80
|
+12.14% (+26,238)
|
|||
|
2021 Q2
|
2.30%
|
$381.80
|
-2.74% (-6,095)
|
|||
|
2021 Q1
|
2.33%
|
$358.95
|
+0.33% (+740)
|
|||
|
2020 Q4
|
2.12%
|
$321.09
|
new
|
|||
|
2015 Q3
|
0.00%
|
$164.14
|
-100% (-987,841)
|
|||
|
2015 Q2
|
2.61%
|
$164.14
|
-7.14% (-75,940)
|
|||
|
2015 Q1
|
2.63%
|
$154.41
|
-20.91% (-281,261)
|
|||
|
2014 Q4
|
2.66%
|
$125.67
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.